181 related articles for article (PubMed ID: 33034107)
1. Neuropathic pain is associated with poor health-related quality of life in adolescents with sickle cell disease: A preliminary report.
Román ME; Highland J; Retherford D; Pan AY; Panepinto JA; Brandow AM
Pediatr Blood Cancer; 2020 Dec; 67(12):e28698. PubMed ID: 33034107
[TBL] [Abstract][Full Text] [Related]
2. Clinically meaningful interpretation of pediatric health-related quality of life in sickle cell disease.
Beverung LM; Varni JW; Panepinto JA
J Pediatr Hematol Oncol; 2015 Mar; 37(2):128-33. PubMed ID: 24942019
[TBL] [Abstract][Full Text] [Related]
3. Neuropathic pain in patients with sickle cell disease.
Brandow AM; Farley RA; Panepinto JA
Pediatr Blood Cancer; 2014 Mar; 61(3):512-7. PubMed ID: 24167104
[TBL] [Abstract][Full Text] [Related]
4. Vaso-occlusive painful events in sickle cell disease: impact on child well-being.
Brandow AM; Brousseau DC; Pajewski NM; Panepinto JA
Pediatr Blood Cancer; 2010 Jan; 54(1):92-7. PubMed ID: 19653296
[TBL] [Abstract][Full Text] [Related]
5. Level of agreement between adolescents' self-assessment and parent proxy report of health-related quality of life in adolescents with sickle cell disease.
Blake A; Guthrie-Dixon N; Grindley M; Barton-Gooden A; Knight-Madden J; Asnani M
Pediatr Blood Cancer; 2020 Apr; 67(4):e28198. PubMed ID: 32020725
[TBL] [Abstract][Full Text] [Related]
6. A psychometric evaluation of the PedsQL Family Impact Module in parents of children with sickle cell disease.
Panepinto JA; Hoffmann RG; Pajewski NM
Health Qual Life Outcomes; 2009 Apr; 7():32. PubMed ID: 19371442
[TBL] [Abstract][Full Text] [Related]
7. Cognitive Abilities Moderate the Effect of Disease Severity on Health-Related Quality of Life in Pediatric Sickle Cell Disease.
Hardy SJ; Bills SE; Wise SM; Hardy KK
J Pediatr Psychol; 2018 Sep; 43(8):882-894. PubMed ID: 29659914
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of neuropathic pain in adolescents with sickle cell disease: A single-center experience.
Cregan M; Puri L; Kang G; Anghelescu D
Pediatr Blood Cancer; 2022 Apr; 69(4):e29583. PubMed ID: 35147289
[TBL] [Abstract][Full Text] [Related]
9. Differences in health-related quality of life in children with sickle cell disease receiving hydroxyurea.
Thornburg CD; Calatroni A; Panepinto JA
J Pediatr Hematol Oncol; 2011 May; 33(4):251-4. PubMed ID: 21516020
[TBL] [Abstract][Full Text] [Related]
10. Association of Sickle Cell Pain & Symptoms on Health-Related Quality of Life Among Pediatric Patients.
Moody KL
J Pain Symptom Manage; 2022 Sep; 64(3):304-309. PubMed ID: 35550166
[TBL] [Abstract][Full Text] [Related]
11. Interventions for treating neuropathic pain in people with sickle cell disease.
Asnani MR; Francis DK; Brandow AM; Hammond Gabbadon CE; Ali A
Cochrane Database Syst Rev; 2019 Jul; 7(7):CD012943. PubMed ID: 31273755
[TBL] [Abstract][Full Text] [Related]
12. Depression and quality of life in children with sickle cell disease: the effect of social support.
Sehlo MG; Kamfar HZ
BMC Psychiatry; 2015 Apr; 15():78. PubMed ID: 25880537
[TBL] [Abstract][Full Text] [Related]
13. Safety and Utility of Quantitative Sensory Testing among Adults with Sickle Cell Disease: Indicators of Neuropathic Pain?
Ezenwa MO; Molokie RE; Wang ZJ; Yao Y; Suarez ML; Pullum C; Schlaeger JM; Fillingim RB; Wilkie DJ
Pain Pract; 2016 Mar; 16(3):282-93. PubMed ID: 25581383
[TBL] [Abstract][Full Text] [Related]
14. Adherence to hydroxyurea, health-related quality of life domains, and patients' perceptions of sickle cell disease and hydroxyurea: a cross-sectional study in adolescents and young adults.
Badawy SM; Thompson AA; Lai JS; Penedo FJ; Rychlik K; Liem RI
Health Qual Life Outcomes; 2017 Jul; 15(1):136. PubMed ID: 28679417
[TBL] [Abstract][Full Text] [Related]
15. Health-Related Quality of Life Assessments by Children and Adolescents with Sickle Cell Disease and Their Parents in Portugal.
Abadesso C; Pacheco S; Machado MC; Finley GA
Children (Basel); 2022 Feb; 9(2):. PubMed ID: 35205003
[TBL] [Abstract][Full Text] [Related]
16. PedsQL™ Multidimensional Fatigue Scale in sickle cell disease: feasibility, reliability, and validity.
Panepinto JA; Torres S; Bendo CB; McCavit TL; Dinu B; Sherman-Bien S; Bemrich-Stolz C; Varni JW
Pediatr Blood Cancer; 2014 Jan; 61(1):171-7. PubMed ID: 24038960
[TBL] [Abstract][Full Text] [Related]
17. Greater number of perceived barriers to hydroxyurea associated with poorer health-related quality of life in youth with sickle cell disease.
Smaldone A; Manwani D; Green NS
Pediatr Blood Cancer; 2019 Jul; 66(7):e27740. PubMed ID: 30941907
[TBL] [Abstract][Full Text] [Related]
18. Agreement between youth and caregiver report of pain and functioning in pediatric sickle cell disease: PedsQL sickle cell disease module.
Alberts NM; Gilbert A; Kang G; Okhomina VI; Flynn JS; Hodges J; Hankins JS; Klosky JL
Pain; 2024 Mar; 165(3):715-722. PubMed ID: 37878652
[TBL] [Abstract][Full Text] [Related]
19. Quality of life and functional capacity are adversely affected in osteoarthritis patients with neuropathic pain.
Aşkın A; Özkan A; Tosun A; Demirdal ÜS; İsnaç F
Kaohsiung J Med Sci; 2017 Mar; 33(3):152-158. PubMed ID: 28254118
[TBL] [Abstract][Full Text] [Related]
20. Responsiveness of the PedsQL to pain-related changes in health-related quality of life in pediatric sickle cell disease.
Schlenz AM; Schatz J; McClellan CB; Roberts CW
J Pediatr Psychol; 2012 Aug; 37(7):798-807. PubMed ID: 22467881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
